The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global mRNA Drug Market Research Report 2025

Global mRNA Drug Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1736026

No of Pages : 88

Synopsis
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
Global mRNA Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA Drug market research.
Key manufacturers engaged in the mRNA Drug industry include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of mRNA Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole mRNA Drug market and estimated to attract more attentions from industry insiders and investors.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global mRNA Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Moderna
  • Pfizer
  • Zydus Cadila
  • Fosun Pharma
  • CureVAC
  • Sri Lankan Microorganisms
  • BioNtech
  • AstraZeneca
  • Janssen

Segment by Type

  • Preventive Vaccines
  • Therapeutic Vaccine
  • Therapeutic Drugs

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia) 
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

The mRNA Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

List of Tables
Table 1. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global mRNA Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global mRNA Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global mRNA Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global mRNA Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global mRNA Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market mRNA Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of mRNA Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Drug, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global mRNA Drug Sales Market Share by Region (2018-2023)
Table 19. Global mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global mRNA Drug Sales Market Share by Region (2024-2029)
Table 21. Global mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global mRNA Drug Revenue Market Share by Region (2018-2023)
Table 23. Global mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global mRNA Drug Revenue Market Share by Region (2024-2029)
Table 25. North America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific mRNA Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific mRNA Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific mRNA Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific mRNA Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific mRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa mRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa mRNA Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa mRNA Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa mRNA Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa mRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global mRNA Drug Sales (K Units) by Type (2018-2023)
Table 51. Global mRNA Drug Sales (K Units) by Type (2024-2029)
Table 52. Global mRNA Drug Sales Market Share by Type (2018-2023)
Table 53. Global mRNA Drug Sales Market Share by Type (2024-2029)
Table 54. Global mRNA Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global mRNA Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global mRNA Drug Revenue Market Share by Type (2018-2023)
Table 57. Global mRNA Drug Revenue Market Share by Type (2024-2029)
Table 58. Global mRNA Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global mRNA Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global mRNA Drug Sales (K Units) by Application (2018-2023)
Table 61. Global mRNA Drug Sales (K Units) by Application (2024-2029)
Table 62. Global mRNA Drug Sales Market Share by Application (2018-2023)
Table 63. Global mRNA Drug Sales Market Share by Application (2024-2029)
Table 64. Global mRNA Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global mRNA Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global mRNA Drug Revenue Market Share by Application (2018-2023)
Table 67. Global mRNA Drug Revenue Market Share by Application (2024-2029)
Table 68. Global mRNA Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global mRNA Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Moderna mRNA Drug Product
Table 74. Moderna Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Pfizer mRNA Drug Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Zydus Cadila Corporation Information
Table 81. Zydus Cadila Description and Business Overview
Table 82. Zydus Cadila mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Zydus Cadila mRNA Drug Product
Table 84. Zydus Cadila Recent Developments/Updates
Table 85. Fosun Pharma Corporation Information
Table 86. Fosun Pharma Description and Business Overview
Table 87. Fosun Pharma mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Fosun Pharma mRNA Drug Product
Table 89. Fosun Pharma Recent Developments/Updates
Table 90. CureVAC Corporation Information
Table 91. CureVAC Description and Business Overview
Table 92. CureVAC mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CureVAC mRNA Drug Product
Table 94. CureVAC Recent Developments/Updates
Table 95. Sri Lankan Microorganisms Corporation Information
Table 96. Sri Lankan Microorganisms Description and Business Overview
Table 97. Sri Lankan Microorganisms mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sri Lankan Microorganisms mRNA Drug Product
Table 99. Sri Lankan Microorganisms Recent Developments/Updates
Table 100. BioNtech Corporation Information
Table 101. BioNtech Description and Business Overview
Table 102. BioNtech mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. BioNtech mRNA Drug Product
Table 104. BioNtech Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca mRNA Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Janssen Corporation Information
Table 111. Janssen Description and Business Overview
Table 112. Janssen mRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Janssen mRNA Drug Product
Table 114. Janssen Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. mRNA Drug Distributors List
Table 118. mRNA Drug Customers List
Table 119. mRNA Drug Market Trends
Table 120. mRNA Drug Market Drivers
Table 121. mRNA Drug Market Challenges
Table 122. mRNA Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of mRNA Drug
Figure 2. Global mRNA Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global mRNA Drug Market Share by Type in 2022 & 2029
Figure 4. Preventive Vaccines Product Picture
Figure 5. Therapeutic Vaccine Product Picture
Figure 6. Therapeutic Drugs Product Picture
Figure 7. Global mRNA Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global mRNA Drug Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global mRNA Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global mRNA Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global mRNA Drug Sales (2018-2029) & (K Units)
Figure 14. Global mRNA Drug Average Price (US$/Unit) & (2018-2029)
Figure 15. mRNA Drug Report Years Considered
Figure 16. mRNA Drug Sales Share by Manufacturers in 2022
Figure 17. Global mRNA Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest mRNA Drug Players: Market Share by Revenue in 2022
Figure 19. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global mRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 22. North America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 23. United States mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe mRNA Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific mRNA Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific mRNA Drug Revenue Market Share by Region (2018-2029)
Figure 34. China mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America mRNA Drug Sales Market Share by Country (2018-2029)
Figure 42. Latin America mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 43. Mexico mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa mRNA Drug Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa mRNA Drug Revenue Market Share by Country (2018-2029)
Figure 49. Turkey mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE mRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of mRNA Drug by Type (2018-2029)
Figure 53. Global Revenue Market Share of mRNA Drug by Type (2018-2029)
Figure 54. Global mRNA Drug Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of mRNA Drug by Application (2018-2029)
Figure 56. Global Revenue Market Share of mRNA Drug by Application (2018-2029)
Figure 57. Global mRNA Drug Price (US$/Unit) by Application (2018-2029)
Figure 58. mRNA Drug Value Chain
Figure 59. mRNA Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’